20/20 Healthcare Partners - aVenture Asset Manager Research
Location
Auburndale, MA, US
Founded
2005
20/20 Healthcare Partners is a global investment firm that focuses on early-stage technology and life science startups. The firm typically invests in companies during Series A, Series C, and other unspecified rounds, providing the necessary capital to help these startups accelerate their growth. Their investment strategy is geared towards innovative companies that can benefit from their strategic advice and domain expertise.
Notable portfolio companies include Coagulo Medical Technologies, EnClear Therapies, PhysIQ, SQZ Biotechnologies, and Variantyx. The firm prides itself on offering value beyond capital, leveraging a proven track record and deep industry experience to support the growth of their investments. Their investment philosophy emphasizes creating value through strategic partnerships and comprehensive support, ensuring that portfolio companies receive not just funding but also critical guidance and expertise.
20/20 Healthcare Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages